drugset / Trial / NCT00812214

Treatment of Insomnia in Migraineurs

NCT00812214

Phase 4 Completed 113 enrolled MedVadis Research Corporation
RandomizedParallel-groupDouble-blindOther

Summary

It is hypothesized that treating insomnia in migraineurs, many of whom also have tension headaches, prolongs total sleep time to the extent that it decreases overall headache frequency. Chronic headache sufferers also feel more tired during the day, undoubtedly affecting daytime functioning, which is hypothesized to improve as well with prolonged total sleep time.

Timeline

Start
2007-04
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Eszopiclone Small molecule 3 mg